Dipeptidyl peptidase-4 inhibitor tablets enhancing incretin levels for glycemic regulation in type 2 diabetes. Distributed by pharmaceutical wholesalers to inpatient facilities, retail outlets, and primary care offices for prescription by endocrinologists in monotherapy or combination therapies.